Onepot Multi-component Synthesis, Characterization and Biological Applications of Dicationic Ionic Liquids
Abstract
A series of dicationic ionic liquids have been prepared and confirmed with FT-IR, 1H NMR,13C NMR,31P NMR as well as High resolution mass spectroscopy impact technique. The present methodology possesses more advantages such as high yields, simple procedure, short reaction times and mild conditions. All the synthesized compounds were evaluated for their antimicrobial activity based on zone of inhibition. The ionic liquid, 4-butane diaminium NI,NI,NI,N4,N4,N4 hexapropyl dibromide was exhibited remarkable activity against Klebsiella pneumoniae, Bacillus subtilis and Staphylococcus aureus with maximum inhibitory zone. These compounds were further evaluated for their total antioxidant capacity. The total antioxidant capacity was maximum in 1,4-butane diaminium N1,N1,N1,N4,N4,N4hexapropyl dibromide. In addition, the anticancer activity of DILs has been determined using human ovarian cancer cell line SK-OV-3, human prostate cancer cell line DU-145 and human leukemia cancer cell line K-562. The detailed synthesis, characterization, total antioxidant capacity, antimicrobial screening data and anticancer activity details are reported.
Keywords: Antibacterial activity, antifungal activity, anticancer assay, antioxidant asssay, dicationic ionic liquids,
Cite this Article
Jebha Starling P., Paul Metilda.Onepot Multi-component Synthesis, Characterization and Biological Applications of Dicationic Ionic Liquids.Research & Reviews: A Journal of Pharmaceutical Science. 2020; 11(2): 16–39p.
Downloads
Additional Files
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |